Navigation Links
Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing
Date:3/21/2011

BEIJING, March 21, 2011 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading manufacturer of medical technology for treating cancer with radiotherapy, will showcase the company's new TrueBeam™ system for image-guided radiotherapy and radiosurgery at the 23rd International Medical Instruments and Equipment Exhibition in Beijing (ChinaMed), March 25-27, 2011.

TrueBeam was designed from the ground up to treat tumors with unprecedented speed and accuracy — including tumors that move during treatment as the patient breathes in and out.  Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, TrueBeam features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology.

"The TrueBeam system was first introduced in the United States last April, and this will be the company's first time showing it to medical professionals in China," said Ling Zhang, business marketing manager for Varian Medical Systems.  "We are very excited about the opportunity to demonstrate the capabilities of this high-powered cancer fighting machine."

Varian will also highlight the company's X-ray products in the ChinaMed exhibit.  These include new technically advanced X-ray tubes and flat panel detectors developed to work together to improve image quality, increase throughput, and reduce the overall cost per procedure.  "With our expanded inventory and product support services in our Beijing facility, our customers will be able to take full advantage of the benefits of digital radiology," said Hsiao-Li Pan, manager of Varian's X-Ray Products business in China.

New Technology SeminarIn addition, Varian will officially introduce TrueBeam in China at a new technology seminar on the afternoon of March 25, 2011, in front of some sixty guests from the 25 top hospitals in China.  Speakers will include Joshua Lawson, M.D., radiation oncologist at the University of California, San Diego Medical Center, and Joseph Ting, PhD, chief medical physicist at the MIMA Cancer Center in Melbourne, Florida.  Dr. Lawson will speak about the clinical advantages of the TrueBeam system.  Dr. Ting's talk will focus on the system's High Intensity Mode, which significantly reduces treatment time, making it possible to treat some cancers that would not have been considered treatable before.

"Varian is pleased to showcase this new world-class solution at ChinaMed this year,” said Thomas P. Duffy, Varian's vice president of sales and marketing for the Asia Pacific region.  "Early adopters from around the world, like Dr. Lawson and Dr. Ting, are using TrueBeam to deliver precise image-guided treatments, providing cancer patients with access to highly personalized, advanced treatment options.”

ABOUT VARIAN MEDICAL SYSTEMSVarian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,400 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. The company's center in Beijing encompasses oncology equipment manufacturing operations, an educational center for radiotherapy clinical professionals, a customer service center, and X-ray Products assembly and service.  For more information, visit http://www.varian.com.FOR INFORMATION CONTACT:UNITED STATES

ASIAMeryl Ginsberg

Ling ZhangTel: 650.424.6444

Tel: +86-10-8785 8800meryl.ginsberg@varian.com

Cell: +86-139-1085 4745ling.zhang@varian.com
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)...  According to the Centers for Disease Control and Prevention (CDC), ... Urgent Care is helping communities across Massachusetts , ... offering no-cost* flu shots through the end of the month. ... regulations. ... a flu shot is by the end of October, according to the ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
Breaking Medicine News(10 mins):